BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4372371)

  • 1. Detection of Epstein-Barr virus-determined intracellular antigens in unfixed cells with labeled antibodies.
    Hilgers F; Rosén A; Lamon E; Klein G
    J Natl Cancer Inst; 1974 Oct; 53(4):949-55. PubMed ID: 4372371
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in frozen and thawed cells and subcellular fractions of human lymphoblastoid cell lines by means of an 125I-IgG binding assay.
    Brown TD; Klein G
    IARC Sci Publ (1971); 1975; (11 Pt 1):351-6. PubMed ID: 190139
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in human lymphoblastoid cell lines by means of an 125-I-IgG-binding assay.
    Brown TD; Ernberg I; Lamon EW; Klein G
    Int J Cancer; 1974 Jun; 13(6):785-94. PubMed ID: 4368574
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
    Yang CS; Hewetson JF
    Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies.
    Reedman BM; Klein G; Pope JH; Walters MK; Hilgers J; Singh S; Johansson B
    Int J Cancer; 1974 Jun; 13(6):755-63. PubMed ID: 4136722
    [No Abstract]   [Full Text] [Related]  

  • 6. Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence.
    Ernberg I; Klein G; Kourilsky FM; Silvestre D
    J Natl Cancer Inst; 1974 Jul; 53(1):61-5. PubMed ID: 4365906
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigen expression and colony formation of lymphoblastoid cell lines after superinfection with Epstein-Barr virus.
    Rocchi G; Hewetson J; Henle W; Henle G
    J Natl Cancer Inst; 1973 Feb; 50(2):307-14. PubMed ID: 4349762
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.
    Klein G; Dombos L; Gothoskar B
    Int J Cancer; 1972 Jul; 10(1):44-57. PubMed ID: 4122458
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma.
    Oldstone MB; Theofilopoulos AN; Gunvén P; Klein G
    Intervirology; 1974; 4(5):292-302. PubMed ID: 4377147
    [No Abstract]   [Full Text] [Related]  

  • 10. An immuno-electron microscopic analysis of Epstein-Barr virus-related antigens in Burkitt lymphoma cells.
    Suzuki I
    Gan; 1972 Oct; 63(5):629-31. PubMed ID: 4345632
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens.
    Reedman BM; Hilgers J; Hilgers F; Klein G
    Int J Cancer; 1975 Apr; 15(4):566-71. PubMed ID: 166941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1972 Oct; 239(95):242-3. PubMed ID: 4343346
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.
    Svedmyr A; Demissie A; Klein G; Clifford P
    J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
    Rocchi G; Hewetson J; Henle W
    Int J Cancer; 1973 May; 11(3):637-47. PubMed ID: 4364719
    [No Abstract]   [Full Text] [Related]  

  • 15. Solid-phase radioimmunoassays for Epstein-Barr virus associated antigens.
    Dölken G; Gier A; Finke J; Weitzmann U
    Ric Clin Lab; 1982; 12(1):307-12. PubMed ID: 6283618
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of antigens determined by the Epstein Barr virus (EBV) in human lymphoblastoid cell culture lines by elution of specific radioiodine labeled antibody.
    Lamon EW; Ernberg I; Klein G
    Clin Immunol Immunopathol; 1974 Jan; 2(2):216-33. PubMed ID: 4361279
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the relation of membrane immunofluorescence to Epstein-Barr virus infection.
    Dunkel VC; Zeigel RF
    J Natl Cancer Inst; 1970 Jan; 44(1):133-44. PubMed ID: 11515024
    [No Abstract]   [Full Text] [Related]  

  • 18. Difference in heat stability of antigens associated with Epstein-Barr virus, demonstrated by immunodiffusion.
    Demissie A
    J Natl Cancer Inst; 1973 Sep; 51(3):751-60. PubMed ID: 4355217
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients.
    Ablashi DV; De-Thé GB; Easton JM; Liabeuf A; Levine PH; Armstrong GR
    Biomedicine; 1974 Jul; 21(7):288-93. PubMed ID: 4139981
    [No Abstract]   [Full Text] [Related]  

  • 20. The variability in immunofluorescent viral capsid antigen antibody tests in population surveys of Epstein-Barr virus infections.
    Geser A; Day NE; de-Thé GB; Chew BK; Freund RJ; Kwan HC; Lavoue MF; Simkovic D; Sohier R
    Bull World Health Organ; 1974; 50(5):389-400. PubMed ID: 4376066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.